Benjamin Guy Davis

This inventor holds 11 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Oxford University Innovation Ltd, Isis Innovation Limited, Psioxus Therapeutics Limited. Active years: 2009-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Benjamin Guy Davis. Retrieved from https://idiyas.com/inventor/benjamin-guy-davis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 7)

% Patents Active = 72.7

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 14(Granted Patents)

Company Filing History:

5 out of 484

Oxford University Innovation Ltd

patents

4 out of 330

Isis Innovation Limited

patents

1 out of 22

Psioxus Therapeutics Limited

patents

4. 1 out of 126

R.p.scherer Technologies, Inc.

patents

Years Active: 2009-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11559581 - Antibody conjugates and methods of making the antibody conjugates (2023-01-24),

2. 10954262 - Tunicamycin analogues (2021-03-23),

3. 10040854 - Antibodies against CD106 (VCAM-1) (2018-08-07),

4. 10016518 - Inflammation imaging and therapy (2018-07-10),

5. 9963518 - Cyclic oligosaccharides for use in the treatment and prevention of bacterial infection (2018-05-08),

6. 9346851 - Chemical modification of proteins (2016-05-24),

7. 9023763 - Modification of trehalose-6-phosphate levels in plants (2015-05-05),

8. 8906345 - Multimeric particles (2014-12-09),

9. 8815563 - Modified virus (2014-08-26),

10. 8637578 - Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins (2014-01-28),

11. 7572604 - Modified carbohydrate processing enzyme (2009-08-11),

Title: Benjamin Guy Davis: Innovator in Antibody Conjugates and Tunicamycin Analogues

Introduction

Benjamin Guy Davis is a prominent inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody conjugates and tunicamycin analogues. With a total of 11 patents to his name, Davis has established himself as a key figure in innovative research.

Latest Patents

Davis's latest patents include groundbreaking work on antibody conjugates and methods of making these conjugates. The described inventions focus on the creation of antibody conjugates that have potential applications in various therapeutic areas. Another notable patent involves tunicamycin analogues, which are compounds that can be utilized in the prevention or treatment of bacterial infections, specifically tuberculosis. These tunicamycin analogues are defined by specific chemical formulas and are considered valuable in pharmaceutical applications.

Career Highlights

Throughout his career, Benjamin Guy Davis has worked with esteemed organizations such as Oxford University Innovation Limited and Isis Innovation Limited. His work in these institutions has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Davis has collaborated with notable colleagues, including Daniel Clive Anthony and Nicola Ruth Sibson. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

In summary, Benjamin Guy Davis is a distinguished inventor whose work in antibody conjugates and tunicamycin analogues has made a substantial impact in biotechnology. His contributions continue to influence the field and pave the way for future innovations.

Profile summary based on public USPTO records.